1. Home
  2. SRPT vs PDYNW Comparison

SRPT vs PDYNW Comparison

Compare SRPT & PDYNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • PDYNW
  • Stock Information
  • Founded
  • SRPT 1980
  • PDYNW 2017
  • Country
  • SRPT United States
  • PDYNW United States
  • Employees
  • SRPT N/A
  • PDYNW 70
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • PDYNW Wholesale Distributors
  • Sector
  • SRPT Health Care
  • PDYNW Industrials
  • Exchange
  • SRPT Nasdaq
  • PDYNW Nasdaq
  • Market Cap
  • SRPT N/A
  • PDYNW N/A
  • IPO Year
  • SRPT 1997
  • PDYNW N/A
  • Fundamental
  • Price
  • SRPT $18.24
  • PDYNW $0.31
  • Analyst Decision
  • SRPT Buy
  • PDYNW
  • Analyst Count
  • SRPT 25
  • PDYNW 0
  • Target Price
  • SRPT $64.00
  • PDYNW N/A
  • AVG Volume (30 Days)
  • SRPT 7.9M
  • PDYNW 210.9K
  • Earning Date
  • SRPT 08-06-2025
  • PDYNW 02-28-2025
  • Dividend Yield
  • SRPT N/A
  • PDYNW N/A
  • EPS Growth
  • SRPT N/A
  • PDYNW N/A
  • EPS
  • SRPT N/A
  • PDYNW N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • PDYNW $7,771,000.00
  • Revenue This Year
  • SRPT $26.87
  • PDYNW N/A
  • Revenue Next Year
  • SRPT $3.15
  • PDYNW N/A
  • P/E Ratio
  • SRPT N/A
  • PDYNW N/A
  • Revenue Growth
  • SRPT 59.15
  • PDYNW N/A
  • 52 Week Low
  • SRPT $16.88
  • PDYNW $0.11
  • 52 Week High
  • SRPT $155.95
  • PDYNW $0.54
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 23.09
  • PDYNW N/A
  • Support Level
  • SRPT $16.88
  • PDYNW N/A
  • Resistance Level
  • SRPT $18.62
  • PDYNW N/A
  • Average True Range (ATR)
  • SRPT 1.40
  • PDYNW 0.00
  • MACD
  • SRPT 0.09
  • PDYNW 0.00
  • Stochastic Oscillator
  • SRPT 6.41
  • PDYNW 0.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About PDYNW Palladyne AI Corp

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

Share on Social Networks: